Streetbeat News

Products Services

ARKB

BITB

BLK

BTCW

FBTC

GBTC

IBIT

Spot Bitcoin ETFs in the US have reached a new all-time high with $676.8 million in daily inflows, led by iShares Bitcoin Trust, Fidelity Wise Origin Bitcoin Fund, Bitwise's Bitcoin ETF, ARK 21Shares Bitcoin ETF, and WisdomTree Bitcoin ETF. Despite Grayscale Bitcoin Trust experiencing outflows, the market sentiment is positive with total inflows nearing $7.4 billion. Trading volumes also hit a record $7.69 billion in one day, primarily driven by BlackRock's iShares Bitcoin ETF. Morgan Stanley is considering adding spot Bitcoin ETF products, highlighting Bitcoin's growing acceptance and potential for increased investment.

Portfolio Pulse from Murtuza Merchant

February 29, 2024 | 1:53 pm

FLNG

GOOG

GOOGL

QQQ

WAB

On CNBC's 'Halftime Report Final Trades,' analysts shared their picks, including puts on Invesco QQQ Trust by Steve Weiss, a highlight on FLEX LNG Ltd.'s 12% dividend yield by Jenny Harrington, Kari Firestone's choice of Westinghouse Air Brake Technologies, and Joe Terranova's selection of Alphabet Inc. Alphabet's CEO addressed issues with the Gemini AI chatbot, while Wabtec and Flex LNG reported their financial results, impacting their stock prices.

Portfolio Pulse from Avi Kapoor

February 29, 2024 | 1:52 pm

COYA

Coya Therapeutics announced it will present data at the AD/PD 2024 Conference on immune system and regulatory T cell contributions in frontotemporal dementia (FTD) patients, including a comprehensive analysis on pro-inflammatory cell phenotypes and Treg dysfunction compared to healthy controls.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:51 pm

OCEA

Ocean Biomedical announced that its joint venture partner, Virion Therapeutics, will present clinical study data at the 2024 APASL Global Liver Meeting. This presentation could highlight significant advancements in liver disease treatment, potentially impacting Ocean Biomedical's reputation and future prospects.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:49 pm

AKRO

Akero Therapeutics announced it will present topline Week 96 results from its Phase 2b HARMONY study, which investigates Efruxifermin in patients with pre-cirrhotic NASH.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:46 pm

AUUD

Auddia Inc. is expected to see ad revenue growth from its proposed acquisition of Radio FM, leveraging improved ad market rates and optimized programmatic CPMs. The near-term integration of Auddia's AI into the Radio FM app aims to offer a premium ad-free AM/FM listening experience for subscribers and provide Auddia's ad-free podcast partners access to a global user base.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:45 pm

BBY

Best Buy is implementing AI to optimize the routing of its in-home delivery and installation trucks, aiming for more efficient scheduling. This strategic move is expected to enhance operational efficiency and customer satisfaction by reducing wait times and improving service reliability.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:45 pm

BBY

LOVE

TSLA

Best Buy announced in a conference call that it plans to increase partnerships with vendors for branded in-store merchandise this year, including notable collaborations with Tesla, Lovesac, and Starlink.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:44 pm

PETV

Results from a clinical study involving Spryng, a product by PetVivo Holdings, were presented at the Veterinary Orthopedic Society Annual Conference. This presentation could indicate positive developments for PetVivo Holdings and its product, Spryng.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 1:39 pm

AMC

AMC Entertainment Holdings Inc (NYSE:AMC) reported a 12% increase in Q4 revenue to $1.1 billion, surpassing the consensus estimate of $1.05 billion. The company also reported a smaller-than-expected quarterly loss of 54 cents per share, against analyst estimates of a 70 cents per share loss. Adjusted EBITDA rose 193% year-over-year to $42.5 million. Despite these positive results, attributed in part to successful Taylor Swift and Beyoncé concert films, AMC shares dropped 10.1% to $4.48. CEO Adam Aron expressed confidence in the company's future, noting efforts to optimize operations and innovate in revenue streams.

Portfolio Pulse from Adam Eckert

February 29, 2024 | 1:38 pm